Showing 1 - 6 of 6
<Emphasis Type="Bold">Objectives: To conduct a cost-utility analysis of two 12-week smoking-cessation interventions in Japan: smoking-cessation counselling by a physician compared with use of varenicline, an oral smoking-cessation drug, in addition to counselling. <Emphasis Type="Bold">Methods: A Markov model was constructed to analyse...</emphasis></emphasis>
Persistent link: https://www.econbiz.de/10011001464
Objective: A cost-effectiveness analysis of oral capecitabine versus intravenous bolus 5-fluorouracil/l-leucovorin (FU/LV) as adjuvant therapy in patients with stage 3 colon cancer was performed from a Japanese healthcare payer perspective. Methods: Adjuvant therapy comprised 24 weeks of...
Persistent link: https://www.econbiz.de/10004982122
Objectives: To conduct a cost-utility analysis of two 12-week smoking-cessation interventions in Japan: smoking-cessation counselling by a physician compared with use of varenicline, an oral smoking-cessation drug, in addition to counselling. Abstract: Methods: A Markov model was constructed to...
Persistent link: https://www.econbiz.de/10004990344
This study offers further evidence indicating that income losses do not significantly affect health state valuations. </AbstractSection> Copyright Adis Data Information BV 2012
Persistent link: https://www.econbiz.de/10011001774
Background: An important methodological issue in economic evaluations of healthcare is how to include productivity costs (the costs related to reduced productivity due to illness, disability and premature death). Traditionally, they were included in the numerator of a cost-effectiveness...
Persistent link: https://www.econbiz.de/10010614401
Current practice in economic evaluation is to assign equal social value to a unit of health improvement ('a QALY is a QALY is a QALY'). Alternative equity positions are typically considered separately from efficiency. One proposal seeks to integrate these two sets of societal concerns by...
Persistent link: https://www.econbiz.de/10008496163